Nanoscale Fabrication, Optimization, Scale-up and Biological Aspects of Pharmaceutical Nanotechnology

<p>1. Fabrication of polymeric core-shell nanostructures<br>2. Emulsification-diffusion method to obtain polymeric nanoparticles: two decades of research<br>3. Tools and Techniques for the optimized synthesis, reproducibility and scale up of desired nanostructures from plant derived material and their role in pharmaceutical properties<br>4. Scale up of biopharmaceuticals production<br>5. Physicochemical and morphological characterization of pharmaceutical nanocarriers and mathematical modelling of drug encapsulation/release mass transfer processes<br>6. Biopharmaceutics and pharmacokinetics of multifunctional nanoparticles<br>7. Technological delivery systems to improve biopharmaceutical properties<br>8. From physicochemically stable nanocarriers to targeted drug delivery: in-vivo pharmacokinetic, pharmacodynamic and biodistribution studies<br>9. Sterile dosage forms loaded nanosystems for parenteral, nasal, pulmonary and ocular administration<br>10. Quantitative Characterization of Targeted Nanoparticulate Formulations for Prediction of Clinical Efficacy<br>11. Analytical tools for reliable in vitro and in vivo performance testing of drug nanocrystals<br>12. Application of one-step affinity purification of drug-binding proteins with practical magnetic nanoparticles to drug discovery<br>13. Molecularly Imprinted Polymers as Separation Tools<br>14. Detection of DNA damage induced by nanomaterials<br>15. Pharmacological usage of an enzyme inhibitor – a selective inhibitor of 3-mercaptopyruvate sulfurtransferase reaction intermediate to control generation of polysulfide<br>16. Regulatory Consideration in Nanotechnology Based Drug Products</p>